Seizumes-500 Tablets (Levetiracetam IP 500) is an antiepileptic drug used to treat partial-onset, myoclonic, and tonic-clonic seizures in epilepsy. It works by stabilizing abnormal brain activity to prevent seizures
Seizumes-500 Tablets (Levetiracetam IP 500) is an antiepileptic drug used to treat partial-onset, myoclonic, and tonic-clonic seizures in epilepsy. It works by stabilizing abnormal brain activity to prevent seizures
Active Ingredient: Levetiracetam IP 500mg (antiepileptic drug).
Inactive Ingredients: Excipients vary by brand but commonly include:
Binders: Microcrystalline cellulose, povidone.
Disintegrants: Sodium starch glycolate, crospovidone.
Lubricants: Magnesium stearate.
Coating: Hypromellose, titanium dioxide (for film-coated tablets).
Epilepsy: Treats partial-onset seizures, myoclonic seizures, and generalized tonic-clonic seizures.
Adjunctive Therapy: Used alongside other antiepileptics.
Off-label: Neuropathic pain, migraine prophylaxis (limited evidence).
Adults: Start with 500mg twice daily; may increase to 1500–3000mg/day (max dose varies).
Children (>1 month): 10–60mg/kg/day in 2 divided doses (based on weight).
Renal Impairment: Reduce dose (e.g., 50% for CrCl <80 mL/min).
Binds to synaptic vesicle protein SV2A, modulating neurotransmitter release (reduces hyperexcitability).
Unlike older antiepileptics, it does not affect GABA or sodium channels.
Common: Drowsiness, dizziness, headache, irritability, infections (e.g., colds).
Serious: Psychiatric effects (aggression, depression, suicidal thoughts), severe rash, hepatitis.
Avoid abrupt withdrawal (risk of seizures).
Monitor for mood/behavior changes (especially in children).
Contraindicated in severe hypersensitivity to levetiracetam.
Pregnancy: Use only if benefits outweigh risks (Category C).
Levetiracetam IP 500mg is a broad-spectrum antiepileptic with unique SV2A-targeted action. While effective for seizures, monitor for psychiatric side effects and adjust doses in kidney disease. Always follow a doctor’s guidance.